IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v47y2024i3d10.1007_s40264-023-01385-2.html
   My bibliography  Save this article

Promoting Collaboration of Regulators and Patients in Improving Drug Safety and Regulatory Decision Making

Author

Listed:
  • Yoong Khean Khoo

    (Duke-NUS Medical School
    Duke-NUS Medical School)

  • John C. W. Lim

    (Duke-NUS Medical School
    Duke-NUS Medical School
    Consortium for Clinical Research and Innovation)

  • Wei Chuen Tan-Koi

    (Duke-NUS Medical School)

  • Nokuthula Sikhethiwe Kitikiti

    (Duke-NUS Medical School
    Takeda Pharmaceuticals International)

  • Ai Ling Sim-Devadas

    (Nanyang Technological University
    Singapore Health Services)

Abstract

Pharmacovigilance involves a continuous process of evaluating, monitoring and communicating the safety profile of a medicine throughout its life cycle. This process involves a range of stakeholders, including national regulatory authorities, industry, health organisations, healthcare providers and patients. Although patients are the end users of medicines and experts in their medical conditions, patient involvement is still nascent in the Asia-Pacific region. While there are positive examples and encouraging trends, several key challenges currently hinder systemic patient involvement in drug safety and regulatory decision making. Systemic issues such as a lack of formalised frameworks or platforms, underdeveloped communication and information exchange channels, and paternalistic health systems constrain greater patient involvement and collaborative regulator-patient activities. Addressing these challenges will greatly advance collaboration among regulators, patients, and patient advocates to enhance drug safety and regulatory decision making.

Suggested Citation

  • Yoong Khean Khoo & John C. W. Lim & Wei Chuen Tan-Koi & Nokuthula Sikhethiwe Kitikiti & Ai Ling Sim-Devadas, 2024. "Promoting Collaboration of Regulators and Patients in Improving Drug Safety and Regulatory Decision Making," Drug Safety, Springer, vol. 47(3), pages 217-225, March.
    • Handle: RePEc:spr:drugsa:v:47:y:2024:i:3:d:10.1007_s40264-023-01385-2
    DOI: 10.1007/s40264-023-01385-2
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-023-01385-2
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40264-023-01385-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:47:y:2024:i:3:d:10.1007_s40264-023-01385-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.